INTRODUCTION
Innate lymphoid cells (ILCs) are an extended family of developmentally related hematopoietic cells, which contribute to host immune defenses. Differentiation of ILC depends on the expression of the transcriptional repressor inhibitor of DNA binding 2 (ID2) and on the common cytokine receptor g-chain. This shared requirement implies the existence of a common ILC progenitor. On the basis of their functional and developmental characteristics, three main groups of ILC have been identified: ILC1, ILC2, and ILC3.
1,2 ILC1 include natural killer (NK) cells and other interferon (IFN)g-producing cells. NK cells play a fundamental role in host defenses, thanks to their ability to kill virus-infected and tumor cells. In addition, they rapidly release cytokines and chemokines involved in early inflammatory responses. 3, 4 Human NK cell function is regulated by an array of inhibitory receptors, including killer Ig-like receptors (KIRs) and CD94/NKG2A, and activating receptors including NKp46, NKp30, and NKp44 (collectively known as natural cytotoxicity receptors (NCRs)), NKG2D, DNAM-1, and CD16. [5] [6] [7] [8] [9] During NK cell differentiation, other transcription factors (TFs) besides ID2 are required. [10] [11] [12] [13] [14] While the nuclear factor interleukin (IL)-3-regulated (also known as E4BP4) TF is involved in early commitment to the NK cell lineage, the T-box expressed in T cells (Tbet/Tbx21) and Eomesodermin (Eomes) TFs are crucial for the acquisition of NK functional properties. 15, 16 Recently, other IFNg-producing ILC1, different from NK cells, have been identified including non-cytotoxic CD127 17 and intraepithelial CD127
. 18 ILC2 require GATA-binding protein 3 and RAR-related orphan receptor a TFs for their development. They are characterized by CD127, CD161, and chemoattractant receptor-homologous molecule expressed on T helper 2 cells (CRTH2) expression, and produce T helper 2-associated cytokines. 19 Finally, group 3 ILC includes different cell types, defined by the requirement of RORgt TF for their development and function and by their ability to produce IL-17 and/or IL-22. 2, 20 Lymphoid tissue inducer (LTi) cells, the first described ILC3, play a key role in the formation of secondary lymphoid organs (SLO) during fetus development. 20 Notably, cells with similar phenotypic characteristics were identified also in adult SLO and were named LTi-like cells. In humans, LTi/ LTi-like cells express CD127 and CD117. 2, 21 A third cell population belonging to group 3 ILC, termed NK22 or NCR þ ILC3, has been recently identified in mucosal tissues. The NCR þ ILC3 population shares common features with NK cells and ILC3, as they express NCRs (NKp44 high NKp46 low ), RORgt TF, and produce IL-22. [22] [23] [24] [25] Regarding the possible role of ILC during pregnancy, so far only NK cells have been identified and functionally characterized in human decidua, where they are thought to contribute to the establishment of an immunosuppressive environment and to play a role in tissue building. 26, 27 Notably, a successful pregnancy requires an early inflammatory phase necessary for implantation, while later the establishment of a regulatory/ immunosuppressive phase is needed to prevent fetal rejection. 28 During the first trimester, decidual NK (dNK) cells represent as much as 50-70% of decidua-infiltrating lymphocytes (DILs). 29 Previous studies indicated that dNK cells may derive from CD34
þ hematopoietic precursors present in situ (dCD34) and/or from immature NK cells already present in endometrial tissue, and/or from peripheral blood NK cells migrated to decidua during the early phase of pregnancy. [30] [31] [32] dNK cells display unique phenotypic characteristics, are poorly cytolytic, 33, 34 and, unlike peripheral blood NK cells, release cytokines/chemokines involved in neo-angiogenesis, tissue remodeling, and placentation. 26, 29, 35, 36 In addition, dNK cells have been shown to induce regulatory T (Tregs) cells in vitro, i.e., cells that are thought to play a major role in the inhibition of maternal immune response and in tolerance induction. 37 In the present study, we identified two additional decidual ILC3 populations, namely LTi-like cells and NCR þ ILC3 and an ILC1 subset that differs from NK cells. Decidual LTi-like cells produced IL-17 and tumor necrosis factor (TNF), while NCR þ ILC3 produced IL-22 and IL-8, whereas decidual ILC1 primarily released IFN-g. LTi-like cells underwent in vitro differentiation into NCR þ ILC3, whereas both NCR þ ILC3 and LTi-like cells only marginally contributed to NK cell generation. Our data suggest that not only dNK cells, but also decidual ILC3 and ILC1 may play a relevant role both in innate defenses and in tissue building/remodeling during the early phases of pregnancy.
RESULTS

Human decidua contains different ILC subsets
Different ILC subsets are present in different organs and are characterized by the secretion of cytokines such as IL-17A, IL-22, IFN-g, and TNF that promote/mediate tissues remodeling, lymphoid organogenesis, inflammation, and antimicrobial immunity. 2 We investigated whether cells producing these cytokines were present in human decidua. To this end, DILs were stimulated with phorbol 12-myristate 13-acetate (PMA)/ ionomicyn/IL-23. After 18 h, the cytokines produced by different cell subsets were analyzed by using the gating strategy shown in Figure 1a . Lineage negative (Lin (Figure 1b-d) . Therefore, in order to verify whether cell populations identified in human decidua indeed included ILC3 and ILC1, a more detailed phenotypic characterization was required.
Characterization of decidual ILC3 and ILC1
The putative decidual ILCs were further analyzed for the expression of CD127, CD117, and NKp44, i.e., markers allowing a more precise identification of ILC subsets. CD56 þ
CD94
þ NK cells were negative for CD127 and CD117 and, when sorted, they produced only IFN-g and TNF ( Figure 2a and Supplementary Figure S1a online). CD127 and CD117 were expressed only by a fraction of CD56 þ CD94 À cells that homogenously expressed also NKp44, as previously described
þ cells produced high amount of IL-8 and IL-22, while they were negative for IFN-g (Supplementary Figure  S1a) . Figure 2a and Supplementary Figure S1a) . Thus,
þ cells likely represent decidual LTi-like cells, and are hereinafter referred to as LTi-like cells (Figure 2a) . Moreover, as shown above (Figure 1b) , we observed that IFN-g expression was not restricted to Figure S1b) . These cells expressed Tbet and Eomes, but not RORgt TF. Notably, similarly to intraepithelial ILC1 (iILC1) identified in gut, 18 they were
we could also identify IFN- Figure S1b) . 17 These data indicate that ILC1 different from NK cells are present in human decidua.
A fundamental requirement to define both NCR þ ILC3 and LTi-like cells is the expression of RORgt TF. As shown in Figure 2b ,c, unlike NK cells, decidual NCR þ ILC3 and LTi-like cells expressed RORgt. On the contrary, NK cells expressed the Eomes TF. In order to further characterize the subset assignment of decidual ILC, we next assessed different markers associated with NK cells, NCR þ ILC3, or LTi-like cells. As shown in Figure 2d , both NCR þ ILC3 and LTi-like cells expressed higher levels of IL-23R, IL-1R1, CCR6, and RANKL compared with NK cells. In line with previous reports, decidual LTi-like cells expressed higher levels of CD25 as compared with NK cells and NCR þ ILC3, while all cell subsets were CD62L negative and displayed bimodal expression of CD7. 21, 24 In addition, NCR þ ILC3 displayed lower LFA-1 expression them NK and LTi-like cell subsets. 40 On the contrary, NCR þ ILC3 expressed higher levels of CXCR5, CD161, and NKp44 compared with NK cells and LTi-like cells. Conversely, NK cells expressed much higher levels of NKp46, NKG2D, KIRs, perforin, and granzyme B compared with NCR þ ILC3 and LTi-like cells. Finally, CRTH2 was barely detectable in all subsets, which suggested that decidual ILC may not contain ILC2. 19 Taken together, these data further confirm that both NCR þ ILC3 and LTi-like cells are present in human decidua during the first trimester of pregnancy.
Decidual NCR þ ILC3 and LTi-like cells respond to cytokine stimulation
It has been shown that upon stimulation with a combination of IL-7, IL-1b, and IL-23, ILC3 release cytokines including IL-22.
38, 41 As shown in Figure 3a ,b, decidual NCR þ ILC3 Thus, we investigated whether decidual NCR þ ILC3 and LTi- like cells could induce upregulation of these adhesion molecules on decidual stromal cells (DSCs). Sorted NK cells, NCR þ ILC3, and LTi-like cells were cocultured with DSCs. After 7 days, DSCs displayed higher expression of ICAM1 and VCAM1 when cultured with NCR þ ILC3 and LTi-like cells as compared with DSCs cultured with NK cells (Figure 3c,d ). These data reveal that cells with LTi activity are present in human decidua.
ILC3 proliferate and partially differentiate toward NK cells
We analyzed whether decidual ILC3 could undergo in vitro proliferation in the presence of cytokines previously shown to promote survival and proliferation of ILC3 isolated from tonsil. 21, 41 The decidual NCR þ ILC3 and LTi-like cells represent a small fraction of total CD45 þ cells. However, their numbers/10 6 CD45 þ cells in decidua were comparable with, if not higher, than that of tonsil ILC3 subsets (Supplementary Figure S2a) . In the presence of IL-2 and IL-7, we observed only marginal proliferation of decidual NCR þ ILC3. Moreover, the combined use of IL-7/IL-2 and IL-7/IL-1b could slightly increase cell proliferation. Much higher proliferation occurred in the presence of feeder cells (irradiated allogeneic peripheral blood mononuclear cells þ LCL 221*G cells) and IL-2 or IL-15 (Supplementary Figure S2b) . Notably, NCR þ ILC3 and LTi-like cells displayed a much higher proliferative capacity in comparison with NK cells (Supplementary Figure S2c) .
IL-15-expanded NK cells maintained their phenotype and upregulated NKp44 expression, compared with freshly isolated cells (Figure 4a,b) . As previously described, CD127 was no longer detectable after culture on both NCR þ ILC3 and LTilike cells (Figure 4a) . 21 Cultured NCR þ ILC3 expressed CD117, CCR6, RANKL, NKp44 and upregulated NKp46 (Figure 4a,b) . Interestingly, a consistent fraction of cultured LTi-like cells seemed to differentiate toward NCR þ ILC3 as suggested by the acquisition of CD56 and NKp44 (Figure 4a,b) . In addition, a fraction of cultured NCR þ ILC3 and CD56 LTi-like cells acquired CD94, a typical feature of NK cells (Figure 4a,b) . However, NCR þ ILC3 and CD56 þ LTi-like cells expressed low levels of LFA-1 (acquired during NK cell differentiation 39, 40 ) and were KIR negative ( Figure 4a ,b and Supplementary Figure S2d) Figure S3c and 
Functional analysis of cultured decidual ILCs
We next investigated whether cells cultured in IL-15 had modified their cytokine profile. As shown in Figure 5a Figure S5a-b) . In view of the ability of NCR þ ILC3 and LTilike cells to partially differentiate toward CD94
þ NK cells, we also assessed whether they could mediate cytolytic activity. IL-15-cultured NCR þ ILC3 and LTi-like cells displayed only marginal cytolytic activity against K562 target cells (Figure 5c ). In particular, NCR þ ILC3 and LTi-like cells displayed 25% target cell lysis at an effector/target (E/T) ratio of 10:1. The same levels of cytolysis was mediated by NK cells and ILC1 at a ratio of 0.3:1, which reveals approximately 30-fold difference in cytolytic activity (Figure 5c and Supplementary Figure S4c) . Similar results were obtained with cells cultured in IL-2 (Supplementary Figure S5c) . Thus, in line with low perforin and granzyme B expression (Supplementary Figure S2f) , both cultured NCR þ ILC3 and LTi-like cells are poorly cytolytic. This confirms that these cells could not differentiate toward mature cytolytic NK cells. À -persisting cell population acquired CD161, NKp44, and partially NKp46 (Figure 6b and Supplementary Figure S6a) . Notably, after culture, CD56
À cells maintained high expression of both RORgt and CD117, similarly to freshly isolated LTi-like cells ( Figure  6c and Supplementary Figure S6b) . In addition, upon PMA/ ionomicyn/IL-23 stimulation, CD56
À cells retained the ability to secrete IL-17A and TNF and also produced IL-8 and IL-22 ( Figure 6d and Supplementary Figure S6c) . We investigated whether the remaining CD56
À cells maintained their features or rather acquired NCR þ ILC3 features upon additional culture. Thus, from LTi-like cells cultured for 20 days, we sorted CD56
À cells and cultured them for additional 10 or 20 days. As shown in Figure 6e , CD56 À cells could maintain their Figure S3c,e) . Taken together, these data suggest that LTi-like cells are heterogeneous, indeed they may contain cells with capability to maintain their phenotypic and functional features as well as to differentiate toward other ILC subsets.
DISCUSSION
In the present study, we show that different ILC populations are present in human decidua during the first trimester of pregnancy. Indeed, in addition to NK cells, decidua contains other IFN-g-producing ILC1. Moreover, we identified two ILC3 populations, NCR þ ILC3 and LTi-like cells, characterized by the ability to produce IL-22/IL-8 and TNF/IL-17A, respectively. Finally, we show that, while NCR þ ILC3 substantially maintain their phenotypic characteristics after culture in IL-15 or IL-2, the majority of LTi-like cells acquire the phenotypic and functional features of NCR þ ILC3. Different ILC populations have been recently identified in different tissues, where they play a role in innate responses and contribute to tissue homeostasis and lymphoid tissue generation. 2, 44 The finding that ILC are also present in human decidua, during the first trimester of pregnancy, suggests that these cells may participate in the immune responses necessary for the maintenance/success of pregnancy. The absolute cell number of decidual ILC3 is very small compared with that of NK cells. However, decidual ILC3 have a frequency comparable, if not higher, with that of tonsil ILC3, suggesting that these cells, similarly to tonsil ILC3, 21, 38, 45 may play a role in decidual tissues. During early pregnancy, the balance between inflammation and tolerance is critical. Indeed, it has been shown that pro-inflammatory cytokines contribute to tissue remodeling and neo-angiogenesis, thus favoring embryo implantation. The inflammatory phase is followed by a regulatory phase characterized by an increase in Tregs and other regulatory cells that prevent immune-mediated fetal rejection. 28 Our present results indicate that NCR þ ILC3 and LTi-like cells present in decidua are capable of producing pro-inflammatory cytokines including IL-8, IL-22, IL-17A, TNF, and IFN-g. These results suggest that ILC3 and ILC1 may be involved in the inflammatory phase of early pregnancy required for embryo implantation. In addition, our data suggest that peculiar functional capabilities, previously thought to be confined to other innate or adaptive immune cells, may be assigned, at least in part, also to ILC populations. For example, it has been proposed that Th17 cells present in the uterus may mediate immune responses against extracellular microbes.
28 Since decidual ILC produce IL-17A and IL-22, it is conceivable that they contribute to antimicrobial defenses during pregnancy.
For a successful pregnancy, building and remodeling of vessels is a fundamental process, which is favored by the presence of cells releasing pro-angiogenic factors, including IL-8, vascular endolthelial growth factor, and heparin-binding-EGF growth factor. 26, 27, 35, 46, 47 
. This finding supports the notion of the existence of a developmental relationship between decidual LTi-like cells and NCR þ ILC3, as suggested by previous reports in other organs. 2, 21 It cannot be excluded that, similar to NK cells, also NCR þ ILC3 and LTi-like cells may derive from a hematopoietic precursor present in decidua. Interestingly, previous studies showed that dCD34 precursors express ID2 TF, which is required for ILC development. 30, 36 These data suggest that dCD34 þ cells contain not only precursors of dNK cells, but also of NCR þ ILC3 and LTi-like cells. Further studies are required to clarify the origin of decidual ILC3.
In conclusion, our study provides clear evidence that different ILC populations are present in human decidua and also sheds light on the developmental relationship among dNK cells, NCR þ ILC3, and LTi-like cells. The ability of ILC1 and ILC3 to release pro-inflammatory cytokines suggests that they may exert an innate antimicrobial role, thus contributing to defenses against infectious agents. In addition, ILC3 may contribute to both tissue building/remodeling and neoangiogenesis through IL-8 production. It is possible that altered ILC differentiation and function may result in pregnancy failure consequent to infection or to deficient tissue and vessel formation.
METHODS
Isolation and culture of DILs and DSCs. We obtained decidua (d) samples at 9-12 weeks of gestation from singleton pregnancies of mothers requesting termination of pregnancy for social reasons at AOUSM-IST (Genova, Italy). Tonsils were obtained from patients undergoing tonsillectomy at the Giannina Gaslini Institute (Genova, Italy). The relevant institutional review boards approved the study and all patients gave their written informed consent according to the Declaration of Helsinki. We isolated cell suspensions from decidual tissue with GentleMacs (Miltenyi Biotec, Bergisch Gladbach, Germany) and cells were then filtered as previously described. 34 Decidua-infiltrating lymphocytes were isolated by Fycoll (Cedarlane, Burlington, Ontario) gradient centrifugation. DILs were subsequently analyzed by flow cytometry or stimulated for cytokine production. To obtain single-cell suspension, tonsils were cut in small pieces, minced, and filtered through a 100-mm strainer before density gradient centrifugation. Tonsil mononuclear cell suspensions were analyzed by flow cytometry. In order to isolate NK cells, NCR þ ILC3, or LTi-like cells, DILs were sorted as described in the results section on FACSAria (BD Bioscience, San Jose, CA), purity was routinely 495%. We plated sorted NK cells, NCR þ ILC3, or LTi-like cells at 1,000 cells per well for bulk cultures or using a limiting dilution approach from 200 to 1 cells per well for clonal assays. Cells were cultured in 96-well plates (Corning, Tewksbury, MA) in RPMI-1640 medium (Lonza, Basel, Switzerland) supplemented with 10% (vol/vol) fetal calf serum (Lonza), 1% (vol/vol) glutamine, and 1% (vol/vol) penicillin, neomycin, and streptomycin antibiotic mixture (Lonza and Cambrex, Charles City, IA), with 50 ng ml À 1 IL-7, 50 ng ml À 1 IL-1b, (Miltenyi), or 1,000 U ml À 1 IL-2 (Peprotech, Rocky Hill, NJ), or with feeder cells (irradiated allogeneic peripheral blood mononuclear cells þ LCL 221*G cells) and 10 ng ml À 1 IL-15 (Miltenyi) or 100 U ml À 1 IL-2. To obtain DSCs, we plated fresh decidual cell suspensions and cultured them in the presence of serum-supplemented RPMI medium, as previously described. 50 After 7 days, we removed non-adherent cells to separate the adherent cell fraction (DSC). Half the medium volume was replaced twice a week. When the cultures nearly reached confluence, they were harvested by treatment with trypsin/EDTA solution (Lonza) and re-plated at 5 Â 10 5 cells per 75-cm 2 tissue culture flasks. DSCs were used in the experiments only after 1-2 expansion passages to ensure depletion of monocytes/macrophages. To perform coculture experiments, DSC and ILC were plated at the ratio of 1/5 in the presence of IL-7.
Flow cytometry analyses and monoclonal antibodies. Cells were stained with the following monoclonal antibodies: IL-17A-FITC; IL-17A-APC; IL-2-APC; NKp44-biotin; CD335 (NKp46)-APC; CD294 (CRTH2)-PE; CD314 (NKG2D)-PE; CD117-APC; CD3-PE and CD25-PE purchased from Miltenyi, Bergisch Gladbach, Germany; IFNg-Alexa647; CD62L-PE; CD45-APC-H7, and CCR6-A647 purchased from BD Bioscience; IL-22-PE; TNFa-eFluor450; IFNgPerCP-Cy5.5; RORgt-PE; CD14-eFluor450; CD19-eFluor450; CD14-APC-eFluor480; CD19-APC-eFluor480; RORgt-APC; Eomes-AlexaFluor647; CD34-PerCP-Cy5.5, and CXCR5-PE purchased from eBioscence, San Diego, CA; CD94-FITC; CD127-BrilliantViolet421; NKp44-APC; CD335-PacifiBlue; CD254 (RANKL)-PE; CD161-PerCP-Cy5.5; CD117-PerCP-Cy5.5; CD127-PerCP-Cy5.5; CD7-FITC; CD11a(LFA-1)-PerCP and -FITC; CD103-PE purchased from BioLegend, San Diego, CA: IL-8-PE; IL-23R-biotin; IL-1R1-PE and CD335(NKp46)-PE purchased from R&D, Minneapolis, MN; CD103-FITC purchased from ImmonuTools, Friesoythe, Germany; Perforin-PE and CD106 (VCAM1)-PE purchased from Ancell, Bayport, MN; CD56-PC7, CD158a,h-PE; CD158e1,e2-PE; CD158b1/b2,j-PE and CD3-ECD purchased from IL-BeckmanCoulter; Streptavidi-AlexFluor700; GranzymeB-PE and Live/dead fixable aqua dead purchased from Invitrogen/Molecular Probes (Carlsbad, CA). ICAM1 was kindly provided by A. Poggi.
For intranuclear staining of TF, cells were stained for surface markers, fixed, and permeabilized with Fixation/Permeabilization buffer (eBioscience) and permeabilization buffer (eBioscience), respectively, according to the manufacturer's instructions. For intracellular cytokine detection, cells were stimulated as indicated in the result section in the presence of 25 ng ml À 1 PMA (Sigma), 1 mg ml À 1 Ionomycin (Sigma-Aldrich, St. Louis, MO), 50 ng ml À 1 IL-23, 50 ng ml À 1 IL-7, and 50 ng ml À 1 IL-1b (Miltenyi) in the presence of GolgiStop (BD). After stimulation, cells were stained for surface markers, fixed, and permeabilized with Cytofix/Cytoperm (BD) and with Perm/Wash (BD), respectively according to the manufacturer's instructions. All samples were analyzed on Gallios Flow Cytometer (Beckman Coulter, Brea, CA). Data analysis was done using FlowJo software (TreeStar, Ashland, OR). SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
